BCL2 and melanoma: Moreover, inhibition of TUG1 expression can downregulate Bcl-2, MMP-9 and cyclin D1 protein, reduce the growth of tumors in melanoma and improve the chemosensitivity of A375 cells to cisplatin and 5-FU (74).